Epitope claims stand firm: Board of Appeal upholds functional antibody patent despite insufficiency attack (T 0326/22)
http://ipkitten.blogspot.com/2025/01/epitope-claims-stand-firm-board-of.html The recent Board of Appeal decision T 0326/22 is yet further confirmation, if any were needed, that functionally-defined antibody claims remain viable at the EPO. In this decision, the Board of Appeal upheld Inhibrx’s European patent EP2812443 directed to a genus of anti-CD47 antibodies defined by their epitope binding and... Continue reading